GlaxoSmithKline News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Trading-Depot	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Trading-Depot

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

23.05.25	GSK Plc: CHMP Recommends Approval Of Blenrep Combinations (RTTNews)
23.05.25	GSK : FDA Approves Nucala As Add-on Maintenance Treatment For Chronic Obstructive Pulmonary Disease (RTTNews)
19.05.25	GSK: Japan Approves Blenrep Combinations To Treat Relapsed/refractory Multiple Myeloma In Adults (RTTNews)
14.05.25	GSK Acquires BP Asset IX Inc. For $2 Bln To Advance Efimosfermin In SLD Treatment (RTTNews)
02.03.23	FDA Panel Backs GSK's RSV Vaccine For Older Adults (RTTNews)
10.02.23	GSK Plc: FDA Grants Approval For Jemperli For Patients With DMMR Recurrent Endometrial Cancer (RTTNews)
10.02.23	US FDA grants regular approval for Jemperli for the treatment of patients with recurrent or advanced mismatch repair-deficient endometrial cancer (PR Newswire)
11.07.22	GSK prepares US for 2022-23 flu season with over 50 million influenza vaccine doses (Businesswire)
29.06.22	GSK Selects Target the Future Grant Recipient in Innovation Challenge Supporting Multiple Myeloma Community (Businesswire)
06.06.22	GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and older (Businesswire)
07.06.19	GSK: Nucala Gets FDA Approval For Two New Self-administration Options (RTTNews)
16.05.19	Thermo Fisher To Buy GSK's API Manufacturing Site In Cork, Ireland For €90 Mln (RTTNews)
01.05.19	GSK Q1 Profit Rises (RTTNews)
29.04.19	ViiV Healthcare Seeks FDA Approval For Two-drug To Treat HIV-1 Infection (RTTNews)
24.04.19	World's First Malaria Vaccine Launched (RTTNews)
18.04.19	Mustang Bio Gallops On Gene Therapy Trial Results For Bubble Boy Disease (RTTNews)
18.04.19	The First Two-Drug Regimen For New HIV Patients (RTTNews)
09.04.19	CNCE Hits A Low, UTHR Throws In The Towel On PAH Drug, ZGNX Plunges On FDA Snub (RTTNews)
09.04.19	GSK: FDA Approves ViiV Healthcare's Dovato - Quick Facts (RTTNews)
29.06.18	Biotech Stocks Facing FDA Decision In July (RTTNews)
29.06.18	Novartis To Spin Off Alcon, Buy Back Up To $5 Bln Of Shares (RTTNews)
14.06.18	ViiV Healthcare: GEMINI 1&2 Studies Meets Primary Endpoint - Quick Facts (RTTNews)
12.06.18	GlaxoSmithKline Names Roger Connor President, Vaccines - Quick Facts (RTTNews)
01.06.18	Novartis Completes Divestment Of Stake In Consumer Healthcare JV - Quick Facts (RTTNews)
29.05.18	GSK Submits Application In Japan For Single Inhaler Triple Therapy FF/UMEC/VI (RTTNews)
21.05.18	GlaxoSmithKline Reports EU Marketing Authorisation For Juluca To Treat HIV (RTTNews)
09.05.18	GSK CFO Simon Dingemans To Retire (RTTNews)
01.05.18	Aqua Security and LogicHub Tie as Winners of Security Current's Security Shark Tank® During RSA 2018 (PR Newswire)
25.04.18	GSK Q1 Pre-tax Profit Down; Backs 2018 Adj. EPS View (RTTNews)
19.04.18	GlaxoSmithKline: IMPACT Study Shows Benefits Of Trelegy Ellipta In COPD Patients (RTTNews)
18.04.18	GlaxoSmithKline, Innoviva Says IMPACT Study Shows Benefits Of Trelegy Ellipta (RTTNews)
12.04.18	GSK To Transfer Rare Disease Gene Therapies To Orchard; Takes 19.9% Equity Stake (RTTNews)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
29.03.18	Teva Wins Reversal Of $235 Mln Glaxo's Coreg Drug Verdict (RTTNews)
27.03.18	GSK To Buyout Novartis' Stake In Consumer Healthcare JV For $13 Bln; Stock Up (RTTNews)
27.03.18	GSK To Acquire Novartis' Stake In Consumer Healthcare JV For $13.0 Bln (RTTNews)
23.03.18	ViiV Healthcare: CHMP Issues Positive Opinion For Juluca - Quick Facts (RTTNews)
23.03.18	GSK Withdraws From Process For Pfizer's Consumer Healthcare Unit; Stock Up (RTTNews)
23.03.18	GlaxoSmithKline: Europe, Japan Approve Shingrix To Prevent Shingles In Adults (RTTNews)
08.03.18	Innoviva, GSK: EU Approves Label Update To Relvar Ellipta In Asthma Patients (RTTNews)
05.03.18	ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis (PR Newswire)
14.02.18	GSK Submits IMPACT Data To EU To Support Trelegy Ellipta's Expanded Labelling (RTTNews)
08.02.18	ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir (RTTNews)
07.02.18	GSK Posts Q4 Loss; Expects To Make Continued Progress In 2018 (RTTNews)
05.02.18	Bloomberg: Glaxo, Reckitt Submit Bids For Pfizer's Consumer Business Unit (RTTNews)
26.01.18	GSK's Shingrix Gets Positive CHMP Opinion For Prevention Of Shingles (RTTNews)
26.01.18	GlaxoSmithKline Gets Positive CHMP Opinion For Label Update Of Relvar Ellipta (RTTNews)
22.01.18	Some Branded Drugs Going Generic In 2018 (RTTNews)
12.01.18	GSK receives FDA approval for expanded indication for FLUARIX® QUADRIVALENT (Influenza Vaccine) for persons 6 months and older (PR Newswire)
27.12.17	Biotech Stocks Facing FDA Decision In January 2018 (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

27.07.22		GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an
06.06.22		GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten
31.05.22		GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal
27.04.22		GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen
13.04.22		GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent
28.02.22		GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft
10.02.22		CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat
09.02.22		GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

27.07.22

GSK-Aktie gefragt: GlaxoSmithKline hebt Jahresziele an

06.06.22

GlaxoSmithKline-Aktie stabil: US-Zulassung für Impfstoff Priorix erhalten

31.05.22

GSK-Aktie legt leicht zu: GlaxoSmithKline erwirbt Biopharma-Spezialisten in Milliardendeal

27.04.22

GSK-Aktie höher: GlaxoSmithKline übertrifft Gewinnerwartungen

13.04.22

GlaxoSmithKline-Aktie tendiert tiefer: GlaxoSmithKline übernimmt Sierra Oncology in Milliardendeal - Sierra-Aktie +38 Prozent

28.02.22

GSK-Aktie im Minus: GlaxoSmithKline beendet RSV-Impfstudie mit Schwangeren - IPO von Consumer-Health-Geschäft

10.02.22

CureVac-Aktie steigt: CureVac beginnt Phase-1-Studie mit Grippeimpfstoff-Kandidat

09.02.22

GSK-Aktie gibt dennoch nach: GlaxoSmithKline verdient im Schlussquartal deutlich mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	26.52	1.18 %	K V
ABB	47.84	1.10 %	K V
CieFinRichemont	159.70	1.01 %	K V
Givaudan	4’167.00	0.82 %	K V
Geberit	606.20	0.66 %	K V
Alcon	71.96	-0.61 %	K V
Roche Hldg G	260.90	-0.61 %	K V
Sonova Hldg	263.10	-0.64 %	K V
Kuehne+Nagel Int	188.90	-0.76 %	K V
Zurich Insur Gr	582.00	-0.85 %	K V

GlaxoSmithKline Aktie VALOR 334234 / ISIN US37733W1053

Nachrichten zu GlaxoSmithKline plc (GSK) (ADRS)

Aktien Top/Flop

GlaxoSmithKline Peer Group Nachrichten

Meistgelesene Nachrichten